Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study

Objective There is limited evidence on the economic implications of assessing patients’ access to personalised treatments through Comprehensive Genomic Profiling (CGP) and Molecular Tumour Board (MTB), prompting the need to analyse their impact on the cost of the cancer diagnostic journey (from hosp...

Full description

Saved in:
Bibliographic Details
Main Authors: Adele Busico, Elena Conca, Filippo de Braud, Claudia Proto, Claudio Vernieri, Claudio Jommi, Siranoush Manoukian, Luca Agnelli, Monica Niger, Federica Perrone, Daniele Lorenzini, Giancarlo Pruneri, Elena Tamborini, Andrea Vingiani, Valentina De Micheli, Victoria Lucia Rabsiun Aramburu, Anna Baggi, Matteo Duca, Alberta Piccolo, Iolanda Capone, Giovanni Gancitano, Matteo Ferrario, Jean Marie Franzini
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/5/e099134.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/15/5/e099134.full

Similar Items